Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
16 March 2004 | Volume 140 Issue 6 | Pages 462-464
This statement summarizes the U.S. Preventive Services Task Force (USPSTF) recommendations on screening for hepatitis C virus (HCV) infection, which are based on the USPSTF's examination of evidence specific to asymptomatic persons for HCV testing and treatment. The complete information on which this statement is based, including evidence tables and references, is available in the accompanying article in this issue and in the summary of the evidence and systematic evidence review on this topic. The complete USPSTF recommendation statement (which includes a brief review of the supporting evidence), the accompanying journal article, and the complete systematic evidence review are available through the USPSTF Web site (http://www.preventiveservices.ahrq.gov). The journal article and the USPSTF recommendation statement are available in print through the Agency for Healthcare Research and Quality Publications Clearinghouse (telephone, 800-358-9295; e-mail, ahrqpubs{at}ahrq.gov).
*For a list of the members of the U.S. Preventive Services Task Force, see the Appendix.
Author and Article Information
From the U.S. Preventive Services Task Force, Agency for Healthcare Research and Quality, Rockville, Maryland.
Disclaimer: The USPSTF recommendations are independent of the U.S. government. They do not represent the views of the Agency for Healthcare Research and Quality, the U.S. Department of Health and Human Services, or the U.S. Public Health Service.
Requests for Single Reprints: Reprints are available from the USPSTF Web site (http://www.preventiveservices.ahrq.gov) and in print through the Agency for Healthcare Research and Quality Publications Clearinghouse (800-358-9295). CLINICAL GUIDELINES
Screening for Hepatitis C Virus Infection in Adults: Recommendation Statement
![]()
Related articles in Annals:
This article has been cited by other articles:
![]() |
T. Lincoln, R. W. Tuthill, S. L. DePietro, M. J. Tocco, K. Keough, and T. J. Conklin Viral Hepatitis, Risk Behaviors, Aminotransferase Levels, and Screening Options at a County Correctional Center Journal of Correctional Health Care, October 1, 2006; 12(4): 249 - 261. [Abstract] [PDF] |
||||
![]() |
M. T. Nguyen, S. K. Herrine, C. A. Laine, K. Ruth, and D. S. Weinberg Description of a New Hepatitis C Risk Assessment Tool Arch Intern Med, September 26, 2005; 165(17): 2013 - 2018. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Alter, L. B. Seeff, B. R. Bacon, D. L. Thomas, M. O. Rigsby, and A. M. Di Bisceglie Testing for Hepatitis C Virus Infection Should Be Routine for Persons at Increased Risk for Infection Ann Intern Med, November 2, 2004; 141(9): 715 - 717. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Calonge and G. Randhawa The Meaning of the U.S. Preventive Services Task Force Grade I Recommendation: Screening for Hepatitis C Virus Infection Ann Intern Med, November 2, 2004; 141(9): 718 - 719. [Abstract] [Full Text] [PDF] |
||||
![]() |
USPSTF Recommends Against Screening for HCV Infection Journal Watch Gastroenterology, March 30, 2004; 2004(330): 8 - 8. [Full Text] |
||||
![]() |
USPSTF Recommends Against Screening for HCV Infection Journal Watch (General), March 26, 2004; 2004(326): 1 - 1. [Full Text] |
||||
Read all Rapid Responses